Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Åke Lernmark

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Diabetologia|December 7, 2017
Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding ratsAnya Medina, Saba Parween, Sara Ullsten, et al.
Pediatrics|October 12, 2017
Co-occurrence of Type 1 Diabetes and Celiac Disease AutoimmunityWilliam Hagopian, Hye-Seung Lee, Edwin Liu, et al.
JCI Insight|March 4, 2025
Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriersLue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Diabetologia|January 6, 2021
First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic riskSuzanne Bennett Johnson, Kristian F Lynch, Roswith Roth, et al.
Pediatric Diabetes|September 25, 2025
Predictors of Transitions From GADA as the Initial Autoantibody to Multiple Autoantibodies of Type 1 Diabetes in Children at Risk by a Dynamic Prediction ModelLu You, Falastin Salami, Roy Tamura, et al.
Diabetes Care|June 18, 2016
Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY StudyKendra Vehik, Kristian F Lynch, Desmond A Schatz, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFAMaria Månsson Martinez, Falastin Salami, Helena Elding Larsson, et al.
Diabetologia|July 30, 2025
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumCarmella Evans-Molina, Yuval Dor, Åke Lernmark, et al.
Diabetes Care|July 30, 2025
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumCarmella Evans-Molina, Yuval Dor, Åke Lernmark, et al.
Diabetologia|August 4, 2017
Understanding and preventing type 1 diabetes through the unique working model of TrialNetManuela Battaglia, Mark S Anderson, Jane H Buckner, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Diabetologia|December 7, 2017
Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding ratsAnya Medina, Saba Parween, Sara Ullsten, et al.
Pediatrics|October 12, 2017
Co-occurrence of Type 1 Diabetes and Celiac Disease AutoimmunityWilliam Hagopian, Hye-Seung Lee, Edwin Liu, et al.
JCI Insight|March 4, 2025
Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriersLue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Diabetologia|January 6, 2021
First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic riskSuzanne Bennett Johnson, Kristian F Lynch, Roswith Roth, et al.
Pediatric Diabetes|September 25, 2025
Predictors of Transitions From GADA as the Initial Autoantibody to Multiple Autoantibodies of Type 1 Diabetes in Children at Risk by a Dynamic Prediction ModelLu You, Falastin Salami, Roy Tamura, et al.
Diabetes Care|June 18, 2016
Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY StudyKendra Vehik, Kristian F Lynch, Desmond A Schatz, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFAMaria Månsson Martinez, Falastin Salami, Helena Elding Larsson, et al.
Diabetologia|July 30, 2025
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumCarmella Evans-Molina, Yuval Dor, Åke Lernmark, et al.
Diabetes Care|July 30, 2025
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumCarmella Evans-Molina, Yuval Dor, Åke Lernmark, et al.
Diabetologia|August 4, 2017
Understanding and preventing type 1 diabetes through the unique working model of TrialNetManuela Battaglia, Mark S Anderson, Jane H Buckner, et al.
Pageof 18